BBY vs TGTX · P/E 14, rev $18.71B vs P/E 18, rev $240.3M
Best Buy Co. Inc (BBY) versus TG Therapeutics Inc (TGTX) — a side-by-side from cached financials, not a winner call.
Best Buy Co. Inc (BBY) is a specialty retail company listed on NYSE.
TG Therapeutics Inc (TGTX) is a biotechnology company listed on NASDAQ.
Latest reported BBY revenue for 2026-08-01 was $18.71B. Net income was $591.0M. BBY currently screens at market cap $15.41B and trailing P/E 13.5.
Latest reported TGTX revenue for 2026-06-30 was $240.3M. Net income was $7.8M. Revenue was up 17.3% from 2026-03-31 to 2026-06-30. TGTX currently screens at market cap $7.88B and trailing P/E 18.0.
BBY currently screens at market cap $15.41B and trailing P/E 13.5. TGTX currently screens at market cap $7.88B and trailing P/E 18.0.
Not investment advice. Open the BBY and TGTX stock pages for the full models.
Not investment advice.